Advancing Alzheimer’s Care: Home-Based tDCS for Affective Symptoms
Exploring the potential of a portable, non-invasive neuromodulation device to alleviate mental health symptoms in individuals with Alzheimer’s disease.
Study at a Glance
Estimated Time Commitment
5 weeks; 30-minute online sessions
Age Eligibility
60 years of age or older.Diagnosis Required
Alzheimer's disease
Medication
Not applicableAlzheimer’s disease affects millions of individuals and their families, often bringing with it not only cognitive decline but also emotional and psychological challenges. Symptoms such as depression, anxiety, irritability and lack of motivation can significantly impact quality of life. A new research study is investigating an innovative approach to address these affective symptoms — using a portable, noninvasive brain stimulation device from the comfort of home.
What is tDCS?
Transcranial Direct Current Stimulation (tDCS) is a form of neuromodulation that delivers low-level electrical currents to targeted areas of the brain. It has shown promise in improving mood and cognitive function in various neurological and psychiatric conditions. This study aims to evaluate the effectiveness of home-based tDCS in alleviating affective symptoms in individuals diagnosed with Alzheimer’s disease.
Study Overview
Duration: 5 weeks
Format: Procedures are conducted remotely via video meetings and take approximately 30 minutes.
Objective: To assess whether home-based tDCS can improve symptoms such as depression, anxiety and lack of motivation in older adults with Alzheimer’s.
Who Can Participate?
You may be eligible to join the study if you meet the following criteria:
- Have a diagnosis of Alzheimer’s disease
- Are 60 years of age or older
- Can speak and read English
- Have a reliable broadband internet connection
- Experience psychiatric symptoms such as:
- Depressed mood
- Anxiety
- Lack of motivation
- Irritability
Compensation
Participants will receive compensation upon completion of the study.
